Readoutin 45d
Ocular Therapeutix, Inc. — OTX-TKI
Phase 3 primary completion: Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration.
- Date
- Jan 2027
- Type
- Readout
- Indication
- Neovascular Age-related Macular Degeneration